Biogeron Inc logo

AGEL - Biogeron Inc Share Price

n/a 0.0  0.0%

Last Trade -

Consumer Defensives
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £36.7k
Position in Universe th / 6715
Unlock AGEL Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2005 2006 2007 2008 2009 2010 2011E 2012E CAGR / Avg
0.53 0.68 0.43 0.26 0.22 0.12 -25.1%
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 September 2011,Biogeron Inc revenues decreased 74% to $26K. Net losstotaled $587K vs. income of $1.3M. Revenues reflect adecrease in demand for the Company's products and servicesdue to unfavorable market conditions. Net loss reflectsForgiveness of debt decrease of 99% to $10K (income), Losson disposal of fixed assets increase from $0K to $331K(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


AGEL Revenue Unlock AGEL Revenue

Net Income

AGEL Net Income Unlock AGEL Revenue

Normalised EPS

AGEL Normalised EPS Unlock AGEL Revenue

PE Ratio Range

AGEL PE Ratio Range Unlock AGEL Revenue

Dividend Yield Range

AGEL Dividend Yield Range Unlock AGEL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AGEL EPS Forecasts Unlock AGEL Revenue
Profile Summary

BioGeron, Inc. (BioGeron), formerly Angel Acquisition Corp., is an early-stage, bio-nutritional supplement designer, manufacturer, wholesaler and retailer. The Company is a part of the Neutraceutica industry. The Company focuses on creating and manufacturing nutraceutical products to both the retail and wholesale markets worldwide. As of March 2, 2012, the Company’s SuperKrill and the Omega 3 Fish Oil were available for direct sales. On August 1, 2011, the Company merged with its wholly owned subsidiary, BioGeron, Inc.

Last Annual December 31st, 2010
Last Interim September 30th, 2011
Incorporated March 10, 1999
No. of Shareholders: 88
No. of Employees: 1
Sector Consumer Defensives
Industry Food & Tobacco
Exchange OTC Markets Group
Shares in Issue 7,905,908,229
Free Float (0.0%)
Eligible for
AGEL Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for AGEL
Upcoming Events for AGEL
Frequently Asked Questions for Biogeron Inc
What is the Biogeron Inc share price?

As of , shares in Biogeron Inc are trading at n/a, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Biogeron Inc share price performed this year?

Shares in Biogeron Inc are currently trading at n/a and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biogeron Inc price has moved by % over the past year.

What are the analyst and broker recommendations for Biogeron Inc?

There are no analysts currently covering Biogeron Inc.

When will Biogeron Inc next release its financial results?

Biogeron Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2012-09-30
What is the Biogeron Inc dividend yield?

Biogeron Inc does not currently pay a dividend.

Does Biogeron Inc pay a dividend?

Biogeron Inc does not currently pay a dividend.

When does Biogeron Inc next pay dividends?

Biogeron Inc does not currently pay a dividend.

How do I buy Biogeron Inc shares?

To buy shares in Biogeron Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biogeron Inc?

Shares in Biogeron Inc are currently trading at n/a, giving the company a market capitalisation of £n/a.

Where are Biogeron Inc shares listed? Where are Biogeron Inc shares listed?

Here are the trading details for Biogeron Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: AGEL
What kind of share is Biogeron Inc?

We were not able to load our ranking data for Biogeron Inc

Is there a Biogeron Inc share price forecast 2021?

We were not able to load any forecast data for Biogeron Inc.

How can I tell whether the Biogeron Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biogeron Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of n/a, shares in Biogeron Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biogeron Inc PE Ratio?

We were not able to find PE ratio data for Biogeron Inc.

Who are the key directors of Biogeron Inc?

We were unable to find the directors for Biogeron Inc.

Who are the major shareholders of Biogeron Inc?

Here are the top five shareholders of Biogeron Inc based on the size of their shareholding:

Similar to AGEL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.